Back to calendar
Immunovant, Inc. (IMVT) Earnings
IMVT reports earnings on Monday, November 9, 2026
earnings report
November 9, 2026
Q3 2026
Est. EPS: $-0.74
Actual EPS: $-0.75
EPS surprise: -19.26%
Company overview
Market Cap$6.0B
PriceUSD 28.88
EPS (TTM)-2.81
52-week high45.42
52-week low21.34
SectorHealth Technology
IndustryBiotechnology
Employees315